Ed Simcox
Private Equity Investor chez Mayo Clinic Platform
Profil
Ed Simcox is currently a Strategic Advisor at Oisin Biotechnologies, Inc., Vice President at Mayo Clinic Platform, and Strategic Advisor & Chief Strategy Officer at Lifeomic Holdings LLC.
Previously, he was a Director at AT&T, Inc. from 2010 to 2014 and Director & Chief Technology Officer at University Health, Inc. from 2006 to 2010.
Mr. Simcox received his undergraduate degree from DePauw University in 1993 and his graduate degree from Robert H.
Mckinney School of Law in 1997.
Postes actifs de Ed Simcox
| Sociétés | Poste | Début |
|---|---|---|
Mayo Clinic Platform
 Mayo Clinic Platform Investment ManagersFinance Mayo Clinic Platform (Mayo Clinic) is a venture capital firm subsidiary of Mayo Clinic founded in 2019. The firm is headquartered in Rochester, Minnesota. | Private Equity Investor | 01/11/2021 |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Consultant / Advisor | 01/04/2020 |
Anciens postes connus de Ed Simcox
| Sociétés | Poste | Fin |
|---|---|---|
| AT&T INC. | Directeur/Membre du Conseil | 01/01/2014 |
| University Health, Inc. | Directeur/Membre du Conseil | 01/08/2010 |
Formation de Ed Simcox
| Robert H. Mckinney School of Law | Graduate Degree |
| DePauw University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AT&T INC. | Communications |
| Entreprise privées | 3 |
|---|---|
Mayo Clinic Platform
Mayo Clinic Platform Investment ManagersFinance Mayo Clinic Platform (Mayo Clinic) is a venture capital firm subsidiary of Mayo Clinic founded in 2019. The firm is headquartered in Rochester, Minnesota. | Finance |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Health Technology |
| University Health, Inc. |
